Back
Otis Worldwide Vs. Alnylam Pharmaceuticals Industry Stock Comparison
Sell
44
OTIS
Otis Worldwide
Last Price:
99.44
Seasonality Move:
10.81%
Sell
35
ALNY
Alnylam Pharmaceuticals
Last Price:
270.06
Seasonality Move:
13.19%
Sell
44
Otis Worldwide (OTIS)
is a Sell
Is Otis Worldwide a Buy, Sell or Hold?
- The current Otis Worldwide [OTIS] share price is $99.44. The Score for OTIS is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
- OTIS is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
35
Alnylam Pharmaceuticals (ALNY)
is a Sell
Is Alnylam Pharmaceuticals a Buy, Sell or Hold?
- The current Alnylam Pharmaceuticals [ALNY] share price is $273.91. The Score for ALNY is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
- ALNY is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
OTIS Stock Price Chart
What is Otis Worldwide's stock price today?
-
The Otis Worldwide share price today is $99.44
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and OTIS is experiencing slight buying pressure.
ALNY Stock Price Chart
What is Alnylam Pharmaceuticals's stock price today?
-
The Alnylam Pharmaceuticals share price today is $273.91
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ALNY is experiencing buying pressure, which is a positive indicator for future bullish movement.
OTIS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.08 | Sell |
| Relative Strength Index (14 RSI): | 42.54 | Sell |
| Chaikin Money Flow: | 339499 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (100.93 - 105.13) | Sell |
| Bollinger Bands (100): | (93.06 - 101.34) | Buy |
ALNY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.53 | Buy |
| Relative Strength Index (14 RSI): | 44.14 | Sell |
| Chaikin Money Flow: | 854887 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (270.99 - 291.37) | Sell |
| Bollinger Bands (100): | (223 - 289.2) | Buy |
OTIS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 100.67 | Sell |
| 20-day SMA: | 102.72 | Sell |
| 50-day SMA: | 98.87 | Buy |
| 200-day SMA: | 96.09 | Buy |
| 8-day EMA: | 100.49 | Sell |
| 20-day EMA: | 101.42 | Sell |
| 50-day EMA: | 99.85 | Sell |
| 200-day EMA: | 95.41 | Buy |
ALNY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 283.39 | Sell |
| 20-day SMA: | 283.12 | Sell |
| 50-day SMA: | 274.41 | Sell |
| 200-day SMA: | 205.7 | Buy |
| 8-day EMA: | 280.46 | Sell |
| 20-day EMA: | 281.6 | Sell |
| 50-day EMA: | 272.95 | Buy |
| 200-day EMA: | 226.73 | Buy |
Otis Worldwide Earnings Growth & OTIS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.05 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.37 per share, and an increase next year of $0.36 per share.
Alnylam Pharmaceuticals Earnings Growth & ALNY Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.86 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.48 per share, and an increase next year of $0.66 per share.
Otis Worldwide Technical Analysis
| Oct 21 | Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | ||||||||||
| 21 | 22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Alnylam Pharmaceuticals Technical Analysis
| Oct 21 | Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | ||||||||||
| 21 | 22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||